Posted in | News | Optics and Photonics

NHG Awarded License to Make and Distribute LightPath Technologies’ GRADIUM Optical Products

LightPath Technologies, a global manufacturer, distributor and integrator of patented optical components and high-level assemblies, has partnered with NHG, a major manufacturer and provider of optical materials, and granted to NHG an exclusive license to manufacture and distribute GRADIUM® glass products in Asia and, in particular, China , using LightPath intellectual property. The license is exclusive, non-assignable, non-transferable and has an initial term of five years.

GRADIUM® lenses are made from LightPath's proprietary axial gradient index glass, with unique refractive qualities that can be manipulated to reduce spherical aberrations and yield performance similar to single-term aspheres, at a fraction of the cost. GRADIUM® lenses, which have been applied as simple singlets or doublets in complex multi-element systems, have been very well received for use in high-power industrial laser systems by many of the world's largest Nd:YAG laser and fiber laser manufacturers. These optics are being included in laser delivery systems spanning a wide variety of products in end markets that include laser cutting, marking, and welding.

Jim Gaynor , President and CEO of LightPath Technologies, stated, "We are pleased and excited to have found such an excellent partner for the distribution of the GRADIUM® product into the Asian and, specifically, the Chinese market. NHG is a well known and respected producer of optical materials in China , and we believe there is potential for additional partnership opportunities with NHG in the future. We believe NHG will be very successful in broadening the exposure of our GRADIUM® products in Asia and that this partnership will continue to expand LightPath's distribution network and contribute to our company's growth throughout China and Asia well into the future."

Recently LightPath announced its strategic initiatives to apply the knowledge and experience developed over the last twenty-five years in the visible optics market to develop a low-cost manufacturing technique for the production of infrared optics. The Company expects commercial sales of various infrared products to launch in the fourth quarter of calendar 2012. Applications of infrared and thermal imaging technology have grown dramatically over the last ten years into various markets including industrial inspection, automotive safety, chemical and biological sensing and security and surveillance. These markets are expected to generate over $20 billion in system-wide sales in 2014.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    LightPath Technologies, Inc.. (2019, February 27). NHG Awarded License to Make and Distribute LightPath Technologies’ GRADIUM Optical Products. AZoOptics. Retrieved on November 21, 2024 from https://www.azooptics.com/News.aspx?newsID=16265.

  • MLA

    LightPath Technologies, Inc.. "NHG Awarded License to Make and Distribute LightPath Technologies’ GRADIUM Optical Products". AZoOptics. 21 November 2024. <https://www.azooptics.com/News.aspx?newsID=16265>.

  • Chicago

    LightPath Technologies, Inc.. "NHG Awarded License to Make and Distribute LightPath Technologies’ GRADIUM Optical Products". AZoOptics. https://www.azooptics.com/News.aspx?newsID=16265. (accessed November 21, 2024).

  • Harvard

    LightPath Technologies, Inc.. 2019. NHG Awarded License to Make and Distribute LightPath Technologies’ GRADIUM Optical Products. AZoOptics, viewed 21 November 2024, https://www.azooptics.com/News.aspx?newsID=16265.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.